))
#496 Replay: Overmedicating in the New CAA Environment — with Mark A. Smith
Manage episode 429194607 series 2176618
Treść dostarczona przez David Saltzman. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez David Saltzman lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
This week's episode delves into the world of pharmacogenomics (PGx) and how it is changing the way we approach medication management. We sit down with a leading expert in the field to discuss the current state of PGx adoption, the challenges it faces in gaining wider acceptance in the medical community, and the potential impact it could have on our healthcare system in the future. From the role of direct-to-consumer testing to the importance of involving clinicians in the decision-making process, we explore the complexities of this emerging field and what it could mean for patient care. Join us for this informative and thought-provoking conversation on the cutting edge of personalized medicine.
What You’ll Learn From This Episode:
1:54 Overmedication: A systemic problem in healthcare.
4:16 The evolution and future of pharmacogenetics (PGx) as a standard of care.
12:44 Implementing pharmacogenomics testing in employer healthcare plans: Overcoming adoption challenges and practical applications.
14:51 The adoption curve of pharmacogenomics testing in healthcare: A bottom-up mission.
17:34 The future of PGx: Adoption by early adopters and the role of payers.
This Episode Originally Aired March 13, 2023
Rozdziały
1. Solving Over-Medication With Pharmacogenomics (00:00:00)
2. The Future of Pharmacogenomics Adoption (00:13:19)
3. Revolutionizing Healthcare Through Behavioral Solutions (00:18:45)
496 odcinków
Udostępnij
